| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 85.15▲ | 85.58▼ | 85.35▲ | 81.20▲ | 79.22▲ |
| MA10 | 85.32▲ | 85.32▲ | 84.83▲ | 79.16▲ | 73.64▲ |
| MA20 | 85.40▲ | 84.60▲ | 82.41▲ | 77.52▲ | 64.45▲ |
| MA50 | 85.21▲ | 81.38▲ | 79.40▲ | 69.56▲ | 52.27▲ |
| MA100 | 84.89▲ | 79.25▲ | 77.77▲ | 62.15▲ | 43.35▲ |
| MA200 | 82.50▲ | 77.48▲ | 75.33▲ | 53.87▲ | 29.96▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.037▼ | -0.122▼ | 0.188▲ | 0.317▲ | 1.834▲ |
| RSI | 53.953▲ | 69.064▲ | 72.165▲ | 69.885▲ | 70.180▲ |
| STOCH | 19.275▼ | 74.429 | 87.624▲ | 76.014 | 67.060 |
| WILL %R | -39.796 | -17.311▲ | -7.437▲ | -3.406▲ | -18.022▲ |
| CCI | 38.307 | 37.484 | 71.213 | 234.747▲ | 109.944▲ |
|
Monday, November 10, 2025 02:38 PM
Following the NDA submission for icotrokinra treatment of adults and adolescents with moderate to severe plaque psoriasis to the U.S. FDA in July, the European Medicines Agency (EMA) application was ...
|
|
Tuesday, October 28, 2025 04:59 PM
In addition to Truist Financial, Protagonist Therapeutics also received a Buy from H.C. Wainwright’s Douglas Tsao in a report issued today. However, on October 23, TR | OpenAI – 4o reiterated a Hold ...
|
|
Tuesday, October 28, 2025 09:55 AM
Truist raised the firm’s price target on Protagonist Therapeutics (PTGX) to $88 from $76 and keeps a Buy rating on the shares. The firm is positive on the recent initiation of Phase 2/3 study in Crohn ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/11/25 | 83.52 | 86.00 | 83.00 | 85.56 | 952,798 |
| 10/11/25 | 80.58 | 84.84 | 79.56 | 83.23 | 1,161,463 |
| 07/11/25 | 80.12 | 80.75 | 76.70 | 79.54 | 882,432 |
| 06/11/25 | 77.07 | 79.92 | 77.00 | 79.78 | 1,139,569 |
| 05/11/25 | 76.50 | 78.12 | 75.55 | 77.88 | 622,953 |
| 04/11/25 | 75.44 | 78.01 | 75.44 | 76.50 | 1,029,019 |
| 03/11/25 | 78.62 | 80.43 | 75.535 | 75.95 | 1,041,567 |
| 31/10/25 | 77.53 | 79.01 | 76.66 | 78.62 | 725,894 |
| 30/10/25 | 77.21 | 78.74 | 76.75 | 77.85 | 839,379 |
| 29/10/25 | 78.06 | 79.00 | 76.485 | 76.69 | 921,216 |
|
|
||||
|
|
||||
|
|